Tumor-infiltrating lymphocytes for melanoma immunotherapy (Englisch)
Freier Zugriff
- Neue Suche nach: Kepp, Oliver
- Neue Suche nach: Liu, Peng
- Neue Suche nach: Zitvogel, Laurence
- Neue Suche nach: Kroemer, Guido
- Neue Suche nach: Kepp, Oliver
- Neue Suche nach: Liu, Peng
- Neue Suche nach: Zitvogel, Laurence
- Neue Suche nach: Kroemer, Guido
In:
OncoImmunology
;
12
, 1
;
2023
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Tumor-infiltrating lymphocytes for melanoma immunotherapy
-
Beteiligte:Kepp, Oliver ( Autor:in ) / Liu, Peng ( Autor:in ) / Zitvogel, Laurence ( Autor:in ) / Kroemer, Guido ( Autor:in )
-
Erschienen in:OncoImmunology ; 12, 1
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:31.12.2023
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Datenquelle:
Inhaltsverzeichnis – Band 12, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
-
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapyValind, Anders / Verhoeven, Bronte Manouk / Enoksson, Jens / Karlsson, Jenny / Christensson, Gustav / Mañas, Adriana / Aaltonen, Kristina / Jansson, Caroline / Bexell, Daniel / Baryawno, Ninib et al. | 2023
-
An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelinSnell, Daniel / Gunde, Tea / Warmuth, Stefan / Chatterjee, Bithi / Brock, Matthias / Hess, Christian / Johansson, Maria / Simonin, Alexandre / Spiga, Fabio Mario / Weinert, Christopher et al. | 2023
-
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by OxaliplatinHan, Nanumi / Wada, Haruka / Kobayashi, Takuto / Otsuka, Ryo / Seino, Ken-Ichiro et al. | 2023
-
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptorRaiter, Annat / Lipovetsky, Julia / Stenbac, Asaf / Lubin, Ido / Yerushalmi, Rinat et al. | 2023
-
PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasisGo, Eun-Jin / Yang, Hannah / Lee, Seung Joon / Yang, Hyun Gul / Shin, Jin A. / Lee, Won Suk / Lim, Hye Seong / Chon, Hong Jae / Kim, Chan et al. | 2023
-
Piezo1 facilitates optimal T cell activation during tumor challengeabiff, muta / Alshebremi, Mohammad / Bonner, Melissa / Myers, Jay T. / Kim, Byung-Gyu / Tomchuck, Suzanne L. / Santin, Alicia / Kingsley, Daniel / Choi, Sung Hee / Huang, Alex Y. et al. | 2023
-
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory diseaseShrestha, Prabha / Astter, Yana / Davis, David A. / Zhou, Ting / Yuan, Constance M. / Ramaswami, Ramya / Wang, Hao-Wei / Lurain, Kathryn / Yarchoan, Robert et al. | 2023
-
Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancerWang, Fulong / Lu, Shixun / Cao, Di / Qian, Juanjuan / Li, Cong / Zhang, Rongxin / Wang, Feng / Wu, Miaoqing / Liu, Yifan / Pan, Zhizhong et al. | 2023
-
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor responseRubio-Pérez, Laura / Lázaro-Gorines, Rodrigo / Harwood, Seandean L. / Compte, Marta / Navarro, Rocío / Tapia-Galisteo, Antonio / Bonet, Jaume / Blanco, Belén / Lykkemark, Simon / Ramírez-Fernández, Ángel et al. | 2023
-
Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selectively eliminate carcinoma cellsBritsch, Isabel / van Wijngaarden, Anne P. / Ke, Xiurong / Hendriks, Mark. A.J.M. / Samplonius, Douwe F. / Ploeg, Emily M. / Helfrich, Wijnand et al. | 2023
-
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapyHenault, David / Stephen, David / St-Hilaire, Pierre-Antoine / Messaoudi, Nouredin / Vandenbroucke-Menu, Franck / Simoneau, Eve / Rong, Zhixia / Plasse, Marylène / Létourneau, Richard / Roy, André et al. | 2023
-
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAdamo, Annalisa / Frusteri, Cristina / Pilotto, Sara / Caligola, Simone / Belluomini, Lorenzo / Poffe, Ornella / Giacobazzi, Luca / Dusi, Silvia / Musiu, Chiara / Hu, Yushu et al. | 2023
-
Cell type-specific induction of ferroptosis to boost antitumor immunityLiu, Jiao / Li, Jingbo / Kang, Rui / Tang, Daolin et al. | 2023
-
Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapyVaxevanis, Christoforos K. / Bauer, Marcus / Subbarayan, Karthikeyan / Friedrich, Michael / Massa, Chiara / Biehl, Katharina / Al-Ali, Haifa Kathrin / Wickenhauser, Claudia / Seliger, Barbara et al. | 2023
-
Altered phenotypic and metabolic characteristics of FOXP3+CD3+CD56+ natural killer T (NKT)-like cells in human malignant pleural effusionWang, Zi-Hao / Zhang, Pei / Peng, Wen-Bei / Ye, Lin-Lin / Xiang, Xuan / Wei, Xiao-Shan / Niu, Yi-Ran / Zhang, Si-Yu / Xue, Qian-Qian / Wang, Hao-Lei et al. | 2023
-
The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in miceAl Olabi, Raghd / Hendy, Abd El Aziz / Alkassab, Mohamad Basem / Alnajm, Karla / Elias, Manahel / Ibrahim, Mary / Carlyle, James R. / Makrigiannis, Andrew P. / Rahim, Mir Munir A et al. | 2023
-
Trial watch: Toll-like receptor ligands in cancer therapyLe Naour, Julie / Kroemer, Guido et al. | 2023
-
ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancerJung, Hae-Yun / Lee, Dae-Keum / Lee, Minwook / Choi, Seung Hee / Park, Joo Dong / Ko, Eun-Su / Lee, Jongwon / Park, Kyung-Soon et al. | 2023
-
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancerSandström Gerdtsson, Anna / Knulst, Mattis / Botling, Johan / Mezheyeuski, Artur / Micke, Patrick / Ek, Sara et al. | 2023
-
Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancerTang, Wen-Fang / Fan, Xiao-Jun / Bao, Hua / Fu, Rui / Liang, Yi / Wu, Min / Zhang, Chao / Su, Jian / Wu, Yi-Long / Zhong, Wen-Zhao et al. | 2023
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conferenceGregucci, Fabiana / Spada, Sheila / Barcellos-Hoff, Mary Helen / Bhardwaj, Nina / Chan Wah Hak, Charleen / Fiorentino, Alba / Guha, Chandan / Guzman, Monica L. / Harrington, Kevin / Herrera, Fernanda G. et al. | 2023
-
Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatmentPenetra, Mafalda / Arnaut, Luís G. / Gomes-da-Silva, Lígia C. et al. | 2023
-
Histamine antagonists promote cancer immunosurveillanceLiu, Peng / Kroemer, Guido / Kepp, Oliver et al. | 2023
-
L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytesSchlichtner, Stephanie / Yasinska, Inna M. / Klenova, Elena / Abooali, Maryam / Lall, Gurprit S. / Berger, Steffen M. / Ruggiero, Sabrina / Cholewa, Dietmar / Milošević, Milan / Gibbs, Bernhard F. et al. | 2023
-
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibodyBähr-Mahmud, Hayat / Ellinghaus, Ursula / Stadler, Christiane R. / Fischer, Leyla / Lindemann, Claudia / Chaturvedi, Anuhar / Diekmann, Jan / Wöll, Stefan / Biermann, Imke / Hebich, Bernhard et al. | 2023
-
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseasesReid, Pankti / Sandigursky, Sabina / Song, Juhee / Lopez-Olivo, Maria A. / Safa, Houssein / Cytryn, Samuel / Efuni, Elizaveta / Buni, Maryam / Pavlick, Anna / Krogsgaard, Michelle et al. | 2023
-
Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemiaFernandez Botana, Iria / Pagano, Giulia / Moussay, Etienne / Paggetti, Jerome et al. | 2023
-
ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancerWang, Guanpeng / Romero, Yeni / Thevarajan, Indhujah / Zolkiewska, Anna et al. | 2023
-
Arsenic trioxide as an inducer of immunogenic cell deathKepp, Oliver / Pan, Hui / Liu, Peng / Kroemer, Guido et al. | 2023
-
Ferroptosis: friend or foe in cancer immunotherapy?Demuynck, Robin / Efimova, Iuliia / Catanzaro, Elena / Krysko, Dmitri V et al. | 2023
-
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALLZiegler, Nicole / Cortés-López, Mariela / Alt, Francesca / Sprang, Maximilian / Ustjanzew, Arsenij / Lehmann, Nadine / El Malki, Khalifa / Wingerter, Arthur / Russo, Alexandra / Beck, Olaf et al. | 2023
-
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancerCarbonnier, Vincent / Le Naour, Julie / Bachelot, Thomas / Vacchelli, Erika / André, Fabrice / Delaloge, Suzette / Kroemer, Guido et al. | 2023
-
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cellsKajihara, Nabeel / Tanaka, Yoshino / Takeuchi, Riko / Kobayashi, Takuto / Tanji, Masafumi / Ataka, Tsukasa / Nakano, Shiho / Yamada, Taisho / Takaoka, Akinori / Hasegawa, Yoshinori et al. | 2023
-
A Chemically Defined TLR3 Agonist with Anticancer ActivityLe Naour, Julie / Thierry, Sylvain / Scuderi, Sarah Adriana / Boucard-Jourdin, Mathilde / Liu, Peng / Bonnin, Marc / Pan, Yuhong / Perret, Clémence / Zhao, Liwei / Mao, Misha et al. | 2023
-
CD11c+ and IRF8+ cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapyTse, Benita C. Y. / Bergamin, Sarah / Steffen, Pascal / Hruby, George / Pavlakis, Nick / Clarke, Stephen J. / Evans, Justin / Engel, Alexander / Kneebone, Andrew / Molloy, Mark P. et al. | 2023
-
Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptorZhao, Jingjing / Dong, Jiebin / Deng, Changwen / Zhang, Qianjing / Sun, Shicheng / Li, Honggang / Bai, Yun / Deng, Hongkui et al. | 2023
-
Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3pBlümke, Juliane / Bauer, Marcus / Vaxevanis, Christoforos / Wilfer, Andreas / Mandelboim, Ofer / Wickenhauser, Claudia / Seliger, Barbara / Jasinski-Bergner, Simon et al. | 2023
-
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumorsLaurent, Pierre-Antoine / Morel, Daphne / Meziani, Lydia / Depil, Stephane / Deutsch, Eric et al. | 2023
-
Cellular senescence enhances adaptive anticancer immunosurveillanceMarin, Ines / Serrano, Manuel / Pietrocola, Federico et al. | 2023
-
Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumorsDing, Jian / Guyette, Sarah / Schrand, Brett / Geirut, Jessica / Horton, Holly / Guo, Guangwu / Delgoffe, Greg / Menk, Ashley / Baeuerle, Patrick A. / Hofmeister, Robert et al. | 2023
-
Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibitionCodarri Deak, Laura / Hashimoto, Masao / Umaña, Pablo / Klein, Christian et al. | 2023
-
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanomaOldan, Jorge D. / Giglio, Benjamin C. / Smith, Eric / Zhao, Weiling / Bouchard, Deeanna M. / Ivanovic, Marija / Lee, Yueh Z. / Collichio, Frances A. / Meyers, Michael O. / Wallack, Diana E. et al. | 2023
-
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinomaRezapour, Azar / Rydbeck, Daniel / Byvald, Fabian / Tasselius, Viktor / Danielsson, Gustaf / Angenete, Eva / Yrlid, Ulf et al. | 2023
-
M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistanceZheng, Naisheng / Wang, Tingting / Luo, Qin / Liu, Yi / Yang, Junyao / Zhou, Yunlan / Xie, Guohua / Ma, Yanhui / Yuan, Xiangliang / Shen, Lisong et al. | 2023
-
Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidisKepp, Oliver / Zitvogel, Laurence / Kroemer, Guido et al. | 2023
-
Mammary carcinoma: toward a realistic mouse model of incurable cancersPérez-Lanzón, Maria / Maiuri, Maria Chiara / Lopez-Otin, Carlos / Kroemer, Guido et al. | 2023
-
Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy responseHijazi, Assia / Antoniotti, Carlotta / Cremolini, Chiara / Galon, Jérôme et al. | 2023
-
Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapyMartinez-Morilla, Sandra / Moutafi, Myrto / Fernandez, Aileen I. / Jessel, Shlomit / Divakar, Prajan / Wong, Pok Fai / Garcia-Milian, Rolando / Schalper, Kurt A. / Kluger, Harriet M. / Rimm, David L. et al. | 2023
-
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitorsBezu, Lucillia / Kepp, Oliver / Kroemer, Guido et al. | 2023
-
Trial watch: beta-blockers in cancer therapyCarnet Le Provost, Killian / Kepp, Oliver / Kroemer, Guido / Bezu, Lucillia et al. | 2023
-
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumorsTran, Bao-Tram Thi / Gelin, Aurore / Durand, Sylvère / Texier, Matthieu / Daste, Amaury / Toullec, Clémence / Benihoud, Karim / Breuskin, Ingrid / Gorphe, Philippe / Garic, Florence et al. | 2023
-
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibitionKoerner, Julia / Horvath, Dennis / Oliveri, Franziska / Li, Jun / Basler, Michael et al. | 2023
-
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockadeNazerai, Loulieta / Willis, Shona Caroline / Yankilevich, Patricio / Di Leo, Luca / Bosisio, Francesca Maria / Frias, Alex / Bertolotto, Corine / Nersting, Jacob / Thastrup, Maria / Buus, Soren et al. | 2023
-
Tumor-infiltrating lymphocytes for melanoma immunotherapyKepp, Oliver / Liu, Peng / Zitvogel, Laurence / Kroemer, Guido et al. | 2023
-
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsPark, Benjamin C. / Narayanan, Sathya / Gavralidis, Alexander / Ye, Fei / Fan, Run / Sullivan, Ryan J. / Boland, Genevieve / Reynolds, Kerry L / Balko, Justin M. / Carlino, Matteo S. et al. | 2023
-
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancerFlieswasser, Tal / Van den Eynde, Astrid / Freire Boullosa, Laurie / Melis, Jöran / Hermans, Christophe / Merlin, Céline / Lau, Ho Wa / Van Audenaerde, Jonas / Lardon, Filip / Smits, Evelien et al. | 2023
-
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesBorm, Frank J. / Smit, Jasper / Bakker, Joyce / Wondergem, Maurits / Smit, Egbert F. / de Langen, Adrianus J. / de Gruijl, Tanja D. et al. | 2023
-
Trial watch: chemotherapy-induced immunogenic cell death in oncologySprooten, Jenny / Laureano, Raquel S. / Vanmeerbeek, Isaure / Govaerts, Jannes / Naulaerts, Stefan / Borras, Daniel M. / Kinget, Lisa / Fucíková, Jitka / Špíšek, Radek / Jelínková, Lenka Palová et al. | 2023
-
Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responsesWen, Jing / Cheng, Shipeng / Wang, Ran / Huang, Yuying / Xu, Long / Ma, Liyan / Ling, Zhiyang / Xu, Jinfu / Zhao, Deping / Zhang, Yaguang et al. | 2023
-
CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor responseCharpentier, Maud / Formenti, Silvia / Demaria, Sandra et al. | 2023
-
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protectionAnderson, Trevor S. / McCormick, Amanda L. / Daugherity, Elizabeth A. / Oladejo, Mariam / Okpalanwaka, Izuchukwu F. / Smith, Savanna L. / Appiah, Duke / Wood, Laurence M. / Lowe, Devin B. et al. | 2023
-
CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesisZhang, Tao / Wahib, Ramez / Zazara, Dimitra E. / Lücke, Jöran / Shiri, Ahmad Mustafa / Kempski, Jan / Zhao, Lilan / Agalioti, Theodora / Machicote, Andres Pablo / Giannou, Olympia et al. | 2023
-
Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancerMarhold, Maximilian / Udovica, Simon / Halstead, Anna / Hirdler, Mona / Ferner, Muna / Wimmer, Kerstin / Bago-Horvath, Zsuzsanna / Exner, Ruth / Fitzal, Florian / Strasser-Weippl, Kathrin et al. | 2023
-
In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancerXu, Tao / Karschnia, Philipp / Cadilha, Bruno Loureiro / Dede, Sertac / Lorenz, Michael / Seewaldt, Niklas / Nikolaishvili, Elene / Müller, Katharina / Blobner, Jens / Teske, Nico et al. | 2023
-
Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumorsBlomberg, Olga S. / Kos, Kevin / Spagnuolo, Lorenzo / Isaeva, Olga I. / Garner, Hannah / Wellenstein, Max D. / Bakker, Noor / Duits, Danique E.M. / Kersten, Kelly / Klarenbeek, Sjoerd et al. | 2023
-
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)Daban, A / Gonnin, C / Phan, L / Saldmann, A / Granier, C / Lillo-Lelouet, A / Le Beller, C / Pouchot, J / Weiss, l / Tartour, E et al. | 2023
-
Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinomaKoh, Benjamin / Tan, Darren Jun Hao / Lim, Wen Hui / Wong, Jeffrey S L / Ng, Cheng Han / Chan, Kai En / Wang, Meng / Yong, Wei Peng / Dan, Yock Young / Wang, Louis Z et al. | 2023
-
Eribulin mesylate exerts antitumor effects via CD103Oya, Kazumasa / Nakamura, Yoshiyuki / Watanabe, Rei / Tanaka, Ryota / Ichimura, Yuki / Kubota, Noriko / Matsumura, Yutaka / Tahara, Hideaki / Okiyama, Naoko / Fujimoto, Manabu et al. | 2023
-
Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progressionWyrobnik, Iris / Steinberg, Miryam / Gelfand, Anat / Rosenblum, Ronen / Eid Mutlak, Yara / Sulimani, Liron / Procaccia, Shiri / Ofran, Yishai / Novak-Kotzer, Hila / Meiri, David et al. | 2023
-
Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironmentChen, Linda / Lee, Nancy / Sarkar, Reith / Katabi, Nora / Li, Yanyun / Morris, Luc / Wong, Richard / Sherman, Eric / Reis-Filho, Jorge S. / Hollmann, Travis et al. | 2023
-
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cellsRusso, Massimo / Panini, Nicolò / Fabbrizio, Paola / Formenti, Laura / Becchetti, Riccardo / Matteo, Cristina / Meroni, Marina / Nastasi, Claudia / Cappelleri, Andrea / Frapolli, Roberta et al. | 2023
-
Non-pharmaceutical interventions to optimize cancer immunotherapyBoesch, Maximilian / Baty, Florent / Rassouli, Frank / Kowatsch, Tobias / Joerger, Markus / Früh, Martin / Brutsche, Martin H. et al. | 2023
-
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancerZhang, Chen / Cao, Kankan / Yang, Moran / Wang, Yiying / He, Mengdi / Lu, Jiaqi / Huang, Yan / Zhang, Guodong / Liu, Haiou et al. | 2023
-
Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cellsRodriguez, Constanza / Araujo Furlan, Cintia L. / Tosello Boari, Jimena / Bossio, Sabrina N. / Boccardo, Santiago / Fozzatti, Laura / Canale, Fernando P. / Beccaria, Cristian G. / Nuñez, Nicolás G. / Ceschin, Danilo G. et al. | 2023
-
Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapyRudqvist, Nils-Petter / Avagyan, Manushak / Chand, Dhan et al. | 2023
-
Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer PatientsPalermo, Belinda / Bottero, Marta / Panetta, Mariangela / Faiella, Adriana / Sperduti, Isabella / Masi, Serena / Frisullo, Giuseppe / Foddai, Maria Laura / Cordone, Iole / Nisticò, Paola et al. | 2023
-
Anti-CD122 antibody restores specific CD8+ T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growthLacotte, Stéphanie / Slits, Florence / Moeckli, Beat / Peloso, Andrea / Koenig, Stéphane / Tihy, Matthieu / El Hajji, Sofia / Gex, Quentin / Rubbia-Brandt, Laura / Toso, Christian et al. | 2023
-
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimeticAlvarez, Maite / Molina, Carmen / Garasa, Saray / Ochoa, Maria C. / Rodriguez-Ruiz, Maria E / Gomis, Gabriel / Cirella, Assunta / Olivera, Irene / Glez-Vaz, Javier / Gonzalez-Gomariz, Jose et al. | 2023
-
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 statusDora, David / Ligeti, Balazs / Kovacs, Tamas / Revisnyei, Peter / Galffy, Gabriella / Dulka, Edit / Krizsán, Dániel / Kalcsevszki, Regina / Megyesfalvi, Zsolt / Dome, Balazs et al. | 2023
-
T-cell dysfunction in natural killer/T-cell lymphomaFeng, Xiaoyan / Meng, Miaomiao / Li, Hongwen / Gao, Yuyang / Song, Wenting / Di, Ruiqing / Li, Zhaoming / Zhang, Xudong / Zhang, Mingzhi et al. | 2023
-
FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancerLu, Lu / Jiang, Yi-Xin / Liu, Xiao-Xia / Jin, Jin-Mei / Gu, Wen-Jie / Luan, Xin / Guan, Ying-Yun / Zhang, Li-Jun et al. | 2023
-
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionFenaux, Jill / Fang, Xin / Huang, Yao-ming / Melero, Cristina / Bonnans, Caroline / Lowe, Earth Light / Palumbo, Tiziana / Lay, Cecilia / Yi, Zuoan / Zhou, Aileen et al. | 2023
-
MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cellsDi Pace, Anna Laura / Pelosi, Andrea / Fiore, Piera Filomena / Tumino, Nicola / Besi, Francesca / Quatrini, Linda / Santopolo, Silvia / Vacca, Paola / Moretta, Lorenzo et al. | 2023
-
Bile acids regulate MAdCAM-1 expression to link the gut microbiota to cancer immunosurveillanceFidelle, Marine / Tian, Ai-Ling / Zitvogel, Laurence / Kroemer, Guido et al. | 2023
-
Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissuesHu, Qikang / Frank, Meredith L. / Gao, Yang / Ji, Liyan / Peng, Muyun / Chen, Chen / Wang, Bin / Hu, Yan / Wu, Zeyu / Li, Jina et al. | 2023
-
Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumorsKrone, Paula / Wolff, Annabell / Teichmann, Julia / Maennicke, Johanna / Henne, Julia / Engster, Leonie / Salewski, Inken / Bergmann, Wendy / Junghanss, Christian / Maletzki, Claudia et al. | 2023
-
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancerKudling, Tatiana V. / Clubb, James H.A. / Pakola, Santeri / Quixabeira, Dafne C.A. / Lähdeniemi, Iris A.K. / Heiniö, Camilla / Arias, Victor / Havunen, Riikka / Cervera-Carrascon, Victor / Santos, Joao M. et al. | 2023
-
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancerThibaudin, Marion / Ghiringhelli, Francois et al. | 2023
-
A mitochondrial checkpoint to adaptive anticancer immunityKepp, Oliver / Liu, Peng / Kroemer, Guido / Galluzzi, Lorenzo et al. | 2023
-
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLCKoeck, Stefan / Amann, Arno / Kern, Johan / Zwierzina, Marit / Lorenz, Edith / Sopper, Sieghart / Zwierzina, Heinz / Mildner, Finn / Sykora, Martina / Sprung, Susanne et al. | 2023
-
Tumor-intrinsic RGS1 potentiates checkpoint blockade response via ATF3-IFNGR1 axisWang, Baojun / Jiang, Bo / Du, Lin / Chen, Wenyuan / Zhang, Qing / Chen, Wei / Ding, Meng / Cao, Wenmin / Gao, Jie / Deng, Yongming et al. | 2023
-
Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesiclesDeng, Jun / Ke, Hui et al. | 2023
-
Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomasEdmonds, Nicole L. / Gradecki, Sarah E / Katyal, Priya / Lynch, Kevin T / Stowman, Anne M / Gru, Alejandro A / Engelhard, Victor H / Slingluff, Craig LJr. / Mauldin, Ileana S. et al. | 2023
-
Gankyrin-mediated interaction between cancer cells and tumor-associated macrophages facilitates prostate cancer progression and androgen deprivation therapy resistancePeng, Guang / Wang, Chao / Wang, Hongru / Qu, Min / Dong, Keqin / Yu, Yongwei / Jiang, Yuquan / Gan, Sishun / Gao, Xu et al. | 2023
-
Expression of OLR1 gene on tumor-associated macrophages of head and neck squamous cell carcinoma, and its correlation with clinical outcomeZhang, Peng / Zhao, Yan / Xia, Xin / Mei, Song / Huang, Yixuan / Zhu, Yingying / Yu, Shuting / Chen, Xingming et al. | 2023
-
CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transportTian, Cheng / Yuan, Huimin / Lu, Yi / He, Henghui / Li, Qing / Li, Senlin / Yang, Jian / Wang, Mengheng / Xu, Ruochen / Liu, Qian et al. | 2023
-
Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying a bispecific T cell engager against hepatocellular carcinomaYuan, Xiangfei / Lu, Yang / Yang, Yuanyuan / Tian, Wencong / Fan, Dongmei / Liu, Ruoqi / Lei, Xiaomin / Xia, Yafei / Yang, Lei / Yan, Shu et al. | 2023
-
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Mukherjee, Debayan / Romano, Erminia / Walshaw, Richard / Zeef, Leo A. H. / Banyard, Antonia / Kitcatt, Stephen J. / Cheadle, Eleanor J. / Tuomela, Karoliina / Pendharkar, Swati / Al-Deka, Aws et al. | 2023
-
Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signalingFidelle, Marine / Lebhar, Isabelle / Zitvogel, Laurence / Kroemer, Guido et al. | 2023
-
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesisLe Naour, Julie / Montégut, Léa / Pan, Yuhong / Scuderi, Sarah Adriana / Cordier, Pierre / Joseph, Adrien / Sauvat, Allan / Iebba, Valerio / Paillet, Juliette / Ferrere, Gladys et al. | 2023
-
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinomaKlümper, Niklas / Wüst, Lennert / Saal, Jonas / Ralser, Damian J. / Zarbl, Romina / Jarczyk, Jonas / Breyer, Johannes / Sikic, Danijel / Wullich, Bernd / Bolenz, Christian et al. | 2023
-
g-NK cells from umbilical cord blood are phenotypically and functionally different than g-NK cells from peripheral bloodGao, Fei / Mora, Mauricio Campos / Constantinides, Michael / Coenon, Loïs / Multrier, Caroline / Vaillant, Loïc / Zhang, Tianxiang / Villalba, Martin et al. | 2023
-
The signaling function of IDO1 incites the malignant progression of mouse B16 melanomaOrecchini, E / Belladonna, ML / Pallotta, MT / Volpi, C / Zizi, L / Panfili, E / Gargaro, M / Fallarino, F / Rossini, S / Suvieri, C et al. | 2023
-
B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNARastogi, Ichwaku / McNeel, Douglas G. et al. | 2023
-
CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variantsQiu, Na / Srikanth, Akshaya / Mulaw, Medhanie / Tharehalli, Umesh / Selvachandran, Shanthiya / Wagner, Martin / Seufferlein, Thomas / Stifter, Katja / Lechel, André / Schirmbeck, Reinhold et al. | 2023
-
Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancerLopez, Ernesto / Hidalgo, Sofía / Roa, Eduardo / Gómez, Javiera / Hermansen Truan, Carlos / Sanders, Evy / Carrasco, Cristian / Pacheco, Rodrigo / Salazar-Onfray, Flavio / Varas-Godoy, Manuel et al. | 2023
-
In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapiesGalat, Yekaterina / Du, Yuchen / Perepitchka, Mariana / Li, Xiao-Nan / Balyasnikova, Irina V / Tse, William T / Dambaeva, Svetlana / Schneiderman, Sylvia / Iannaccone, Philip M / Becher, Oren et al. | 2023
-
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1Pilgrim, Adeiye A. / Jonus, Hunter C. / Ho, Andrew / Cole, Anna C. / Shim, Jenny / Goldsmith, Kelly C. et al. | 2023
-
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCsLepper, Alisa / Bitsch, Rebekka / Özbay Kurt, Feyza Gül / Arkhypov, Ihor / Lasser, Samantha / Utikal, Jochen / Umansky, Viktor et al. | 2023
-
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapiesGide, Tuba N. / Paver, Elizabeth C. / Yaseen, Zarwa / Maher, Nigel / Adegoke, Nurudeen / Menzies, Alexander M. / Pires da Silva, Ines / Wilmott, James S. / Long, Georgina V. / Scolyer, Richard A. et al. | 2023
-
A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCCWu, Huiting / Liu, Chang / Yuan, Qiang / Qiao, Yan / Ding, Yongwei / Duan, Lina / Li, Wenjing / Zhang, Mengjia / Zhang, Xuhua / Jiang, Yanan et al. | 2023
-
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse modelsDi Trani, Claudia Augusta / Cirella, Assunta / Arrizabalaga, Leire / Bella, Ángela / Fernandez-Sendin, Myriam / Russo-Cabrera, Joan Salvador / Gomar, Celia / Olivera, Irene / Bolaños, Elizabeth / González-Gomariz, José et al. | 2023
-
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitroEsteso, Gloria / Felgueres, María José / García-Jiménez, Álvaro F. / Reyburn-Valés, Christina / Benguría, Alberto / Vázquez, Enrique / Reyburn, Hugh T. / Aguiló, Nacho / Martín, Carlos / Puentes, Eugenia et al. | 2023
-
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignanciesBigenwald, Camille / Haddad, Yacine / Thelemaque, Cassandra / Carrier, Agathe / Birebent, Roxanne / Ly, Pierre / Flament, Caroline / Lahmar, Imran / de Sousa, Eric / Maeurer, Markus et al. | 2023
-
CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppressionChen, Ziqing / Tong, Le / Neo, Shi Yong / Li, Shuijie / Gao, Jiwei / Schlisio, Susanne / Lundqvist, Andreas et al. | 2023
-
Melanoma-associated repair-like Schwann cells suppress anti-tumor T-cells via 12/15-LOX/COX2-associated eicosanoid productionKruglov, Oleg / Vats, Kavita / Soman, Vishal / Tyurin, Vladimir A. / Tyurina, Yulia Y. / Wang, Jiefei / Williams, Li’an / Zhang, Jiying / Donahue Carey, Cara / Jaklitsch, Erik et al. | 2023
-
Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppressionPavicic, Paul G.Jr. / Rayman, Patricia A. / Swaidani, Shadi / Rupani, Amit / Makarov, Vladimir / Tannenbaum, Charles S. / Edwards, Robert P. / Vlad, Anda M. / Diaz-Montero, C. Marcela / Mahdi, Haider et al. | 2023
-
Studying TIGIT activity against tumors through the generation of knockout miceRishiq, Ahmed / Bsoul, Reem / Pick, Ophir / Mandelboim, Ofer et al. | 2023
-
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibitionvan den Ende, Tom / Ezdoglian, Aiarpi / Baas, Lisanne M. / Bakker, Joyce / Lougheed, Sinéad M. / Harrasser, Micaela / Waasdorp, Cynthia / van Berge Henegouwen, Mark I. / Hulshof, Maarten C.C.M. / Haj Mohammad, Nadia et al. | 2023
-
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cellsJin, Xin / Xie, Danni / Sun, Rui / Lu, Wenyi / Xiao, Xia / Yu, Yibing / Meng, Juanxia / Zhao, Mingfeng et al. | 2023
-
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patientsGarcía-Mulero, Sandra / Fornelino, Roberto / Punta, Marco / Lise, Stefano / Varela, Mar / del Carpio, Luis P. / Moreno, Rafael / Costa-García, Marcel / Rieder, Dietmar / Trajanoski, Zlatko et al. | 2023
-
Dipeptidyl peptidase 4 inhibition sensitizes radiotherapy by promoting T cell infiltrationTian, Yu / Kong, Lingyi / Li, Yan / Liao, Zhiyun / Cai, Xing / Deng, Suke / Yang, Xiao / Zhang, Bin / Wang, Yijun / Zhang, Zhanjie et al. | 2023
-
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosisBella, Ángela / Melero, Ignacio / Berraondo, Pedro / Aranda, Fernando et al. | 2023
-
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Reschke, Robin / Gajewski, Thomas F et al. | 2023
-
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumorsBrownlie, Demi / von Kries, Andreas / Valenzano, Giampiero / Wild, Nicole / Yilmaz, Emel / Säfholm, Jesper / Al-Ameri, Mamdoh / Alici, Evren / Ljunggren, Hans-Gustaf / Schliemann, Igor et al. | 2023
-
CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockadeBossio, Sabrina N. / Abrate, Carolina / Tosello Boari, Jimena / Rodriguez, Constanza / Canale, Fernando P. / Ramello, María C. / Brunotto, Valentina / Richer, Wilfrid / Rocha, Dario / Sedlik, Christine et al. | 2023